March 23, 2018

CMS finalizes National Coverage Determination for Next Generation Sequencing Tests for advanced cancer

Brooke Bumpers, Elizabeth Halpern, Beth Roberts, Helen Trilling, Ronald Wisor, Jr.

Hogan Lovells

+ Follow Contact

Send

Embed

On Friday, March 16, Centers for Medicare & Medicaid Services (CMS) finalized its National Coverage Determination (NCD) for Next Generation Sequencing (NGS) tests for Medicare beneficiaries with advanced cancer.

Please see full publication below for more information.

View PDF

Download PDF [328KB]

Report

LOADING PDF: If there are any problems, click here to download the file.

Send Report

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations. Attorney Advertising.